Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrotic Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Not applicableStudy completedNCT07169253
What this trial is testing

Prognostic Score Comparison in IPF and HP

Who this might be right for
IPFFibrotic Lung DiseaseHypersensitivity Pneumonitis+1 more
Saglik Bilimleri Universitesi 143
Early research (Phase 1)Study completedNCT03422068
What this trial is testing

This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 15
Not applicableLooking for participantsNCT06655090
What this trial is testing

Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

Who this might be right for
Interstitial Lung Disease (ILD)
Dai Huaping 10,000
Testing effectiveness (Phase 2)Study completedNCT03221257
What this trial is testing

Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate

Who this might be right for
Scleroderma, SystemicInterstitial Lung Disease
Michael Roth 51
Not applicableLooking for participantsNCT06751069
What this trial is testing

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

Who this might be right for
Lung FibrosisLung Interstitial Disease
Mayo Clinic 460
Not applicableLooking for participantsNCT07332117
What this trial is testing

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 30
Early research (Phase 1)Active Not RecruitingNCT04262167
What this trial is testing

Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease
University of North Carolina, Chapel Hill 24
Not applicableStudy completedNCT04316780
What this trial is testing

Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes

Who this might be right for
Idiopathic Pulmonary Fibrosis
Steward St. Elizabeth's Medical Center of Boston, Inc. 320
Post-approval studies (Phase 4)Study completedNCT05799755
What this trial is testing

Myositis Interstitial Lung Disease Nintedanib Trial

Who this might be right for
Myositis Associated Interstitial Lund Disease (MA-ILD)
Rohit Aggarwal, MD 49
Not applicableEnrolling By InvitationNCT07512687
What this trial is testing

Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia

Who this might be right for
Interstitial Lung DiseaseChronic Obstructive Pulmonary DiseaseHypoxemia
State University of New York at Buffalo 24
Not applicableStudy completedNCT03737409
What this trial is testing

PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial

Who this might be right for
Fibrotic Interstitial Lung Disease
Monash University 116
Large-scale testing (Phase 3)Enrolling By InvitationNCT04905693
What this trial is testing

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseProgressive Pulmonary Fibrosis
United Therapeutics 1,850
Testing effectiveness (Phase 2)UnknownNCT01450644
What this trial is testing

Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease

Who this might be right for
Lung Disease
Royal Marsden NHS Foundation Trust 52